We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Effective Breast-Conserving Surgery Results in Substantial Savings

By HospiMedica International staff writers
Posted on 08 Jan 2019
Print article
A new study suggests that if breast-conserving surgery (BCS) re-operation rates can be minimized, considerable funds can be saved.

Researchers at Imperial College London (Imperial; United Kingdom) and Imperial College Healthcare NHS Trust (London, United Kingdom) conducted a study to compare direct patient‐level costs between 153 patients undergoing successful, definitive BCS and 59 patients who necessitated reoperations. Financial data over the 12-month study period were retrieved using patient‐level information and costing systems (PLICS). In addition, a systematic review of health economic analysis was conducted using the quality of health economic studies (QHES) instrument.

The results revealed that the median cost of reoperations after BCS was USD 6,014, representing an additional USD 2,848 per patient compared with BCS without reoperation. The median QHES score was 47, with only two of nine studies scored in the upper QHES quartile (a score at least 75). Costs of initial lumpectomy and reoperation were in the range USD 1,234-11,786 and USD 655-9136, respectively. The study was published on December 19, 2018, in the British Journal of Surgery (BJS).

“High rates of reoperation following breast‐conserving surgery for positive margins are associated with costs to healthcare providers,” concluded lead author Yasmin Grant, PhD, of the Department of BioSurgery and Surgical Technology at Imperial College London, and colleagues. “If these cost estimates are applied nationally, they provide compelling encouragement to seek interventions to minimize re-operation after BCS, which would reduce associated costs.”

One of the root causes for the variability in repeat surgery rates for BCS is the lack of standardization of an acceptable margin width. No nationally or internationally accepted guidelines for an adequate margin width for invasive or noninvasive breast cancer have as yet been established, leading to considerable variability in BCS re-excision rates.

Related Links:
Imperial College London
Imperial College Healthcare NHS Trust

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
LED Examination Light
LUVIS-E100

Print article

Channels

Critical Care

view channel
Image: Researchers have developed a novel risk score for cardiovascular complications after bone marrow transplant (Photo courtesy of 123RF)

Novel Tool Predicts Cardiovascular Risks after Bone Marrow Transplantation

Every year, thousands of people undergo bone marrow transplants to potentially cure serious diseases like leukemia, lymphoma, and immune deficiency disorders. While these transplants can be lifesaving,... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.